Cargando…

Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor

Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectrosco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi, Nastaran, Moradi, Shahram, Iraji, Aida, Mahdavi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658973/
https://www.ncbi.nlm.nih.gov/pubmed/37981674
http://dx.doi.org/10.1186/s13065-023-01077-z
_version_ 1785148267943690240
author Ghasemi, Nastaran
Moradi, Shahram
Iraji, Aida
Mahdavi, Mohammad
author_facet Ghasemi, Nastaran
Moradi, Shahram
Iraji, Aida
Mahdavi, Mohammad
author_sort Ghasemi, Nastaran
collection PubMed
description Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectroscopy techniques, including FTIR, Mass, (1)H-NMR, and (13)C-NMR. Next, the inhibitory activities of all derivatives were examined against tyrosinase, and, 6a as the most potent compound, exhibited an IC(50) value of 28.50 µM. Furthermore, the kinetic study of 6a was performed to better understand the inhibitory mechanism and its type of inhibition. The UV/Vis spectra analysis was also executed to provide valuable evidence supporting the inhibitory mechanism of compound 6a in the context of tyrosinase inhibition. Also, molecular docking and dynamic molecular study of 6a were executed to study its interactions within the enzyme’s binding site. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-01077-z.
format Online
Article
Text
id pubmed-10658973
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106589732023-11-19 Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor Ghasemi, Nastaran Moradi, Shahram Iraji, Aida Mahdavi, Mohammad BMC Chem Research Tyrosinase, the rate-limiting enzyme of melanogenesis, plays a crucial role in hyperpigmentation. As a result, in this study, a novel class of thiazolopyrimidine derivatives was developed and synthesized as tyrosinase inhibitor. The structure of derivatives was characterized using various spectroscopy techniques, including FTIR, Mass, (1)H-NMR, and (13)C-NMR. Next, the inhibitory activities of all derivatives were examined against tyrosinase, and, 6a as the most potent compound, exhibited an IC(50) value of 28.50 µM. Furthermore, the kinetic study of 6a was performed to better understand the inhibitory mechanism and its type of inhibition. The UV/Vis spectra analysis was also executed to provide valuable evidence supporting the inhibitory mechanism of compound 6a in the context of tyrosinase inhibition. Also, molecular docking and dynamic molecular study of 6a were executed to study its interactions within the enzyme’s binding site. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-01077-z. Springer International Publishing 2023-11-19 /pmc/articles/PMC10658973/ /pubmed/37981674 http://dx.doi.org/10.1186/s13065-023-01077-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ghasemi, Nastaran
Moradi, Shahram
Iraji, Aida
Mahdavi, Mohammad
Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
title Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
title_full Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
title_fullStr Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
title_full_unstemmed Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
title_short Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
title_sort thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658973/
https://www.ncbi.nlm.nih.gov/pubmed/37981674
http://dx.doi.org/10.1186/s13065-023-01077-z
work_keys_str_mv AT ghaseminastaran thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor
AT moradishahram thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor
AT irajiaida thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor
AT mahdavimohammad thiazolopyrimidinederivativesasnovelclassofsmallmoleculetyrosinaseinhibitor